Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra, José G. van den Berg, Arend G. J. Aalbers, Karolina Sikorska, Marta López‐Yurda, Cecile Grootscholten, Geerard L. Beets, Pétur Snæbjörnsson, Monique Maas, Marjolijn Mertz, Vivien Veninga, Gergana Bounova, Annegien Broeks, Regina G. H. Beets‐Tan, Thomas R. de Wijkerslooth, Anja U. van Lent, Hendrik A. Marsman, Elvira Nuijten, Niels F. M. Kok, Maria Kuiper, Wieke H.M. Verbeek, Marleen Kok, Monique E. van Leerdam, Ton N. Schumacher, Emile E. Voest, John B.A.G. Haanen
Topics & Concepts
NivolumabMedicineIpilimumabOncologyTremelimumabInternal medicineColorectal cancerImmunotherapyCancerCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesColorectal and Anal Carcinomas